Holen Sie sich die Stockscreener-App
0.675
0.84%
0.0056
Schlusskurs vom Vortag:
$0.6694
Offen:
$0.66
24-Stunden-Volumen:
39,466
Relative Volume:
0.94
Marktkapitalisierung:
$32.55M
Einnahmen:
Nettoeinkommen (Verlust:
$-7.33M
KGV:
-1.8179
EPS:
-0.3713
Netto-Cashflow:
$-8.02M
1W Leistung:
-14.03%
1M Leistung:
-8.94%
6M Leistung:
-6.60%
1J Leistung:
-78.97%
1-Tages-Spanne:
$0.65
$0.6787
1-Wochen-Bereich:
$0.65
$0.7629
52-Wochen-Spanne:
$0.55
$10.00
Genenta Science Spa Adr Stock (GNTA) Company Profile
Firmenname
Genenta Science Spa Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare GNTA vs MMM, HON, VMI, BBUC, GHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GNTA
Genenta Science Spa Adr
|
0.675 | 32.55M | 0 | -7.33M | -8.02M | -0.3713 |
MMM
3 M Co
|
164.75 | 84.97B | 25.02B | 2.80B | 2.06B | 5.1834 |
HON
Honeywell International Inc
|
211.41 | 67.00B | 39.66B | 4.53B | 4.20B | 14.11 |
VMI
Valmont Industries Inc
|
444.53 | 8.58B | 4.16B | 375.05M | 345.54M | 18.02 |
BBUC
Brookfield Business Corp
|
26.52 | 5.45B | 11.64B | -650.00M | 71.34M | -8.344 |
GHC
Graham Holdings Co
|
1,203.26 | 5.10B | 4.98B | 306.64M | 285.69M | 67.59 |
Genenta Science Spa Adr Stock (GNTA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-06-29 | Fortgesetzt | ROTH MKM | Buy |
| 2022-07-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-01-13 | Eingeleitet | Maxim Group | Buy |
Genenta Science Spa Adr Aktie (GNTA) Neueste Nachrichten
At $1.30 a share, Fin Posillipo buys depositary shares in Genenta Science (Nasdaq: GNTA). - Stock Titan
Sòphia High Tech Flight Hardware on Board VEGA-C VV30 as the European Launcher Carries Sentinel-3C and FLEX into Orbit - marketscreener.com
Genenta Science Delays Vote on Corporate Name Change After Shareholder Pushback - TipRanks
Genenta Science (NASDAQ: GNTA) Transitions Strategy Following Full Acquisition of A.T.C. - Kalkine Media
Genenta Science Accelerates Shift to Aerospace and Defense With Industrial Consolidation Strategy - TipRanks
Genenta Science (GNTA) Holds Firm at $1.30 as Shares Consolidate Near Key SupportMomentum Breakout Ideas - www.dars.gov.et
Enterprise value to EBITDA forward of Genenta Science SpA Sponsored ADR – MUN:K5F - TradingView
Genenta Science Shareholders Approve Major Capital Authorization and Reverse Split Plan - TipRanks
Genenta Science (GNTA) backs capital and reverse split plans - Stock Titan
Genenta Science SpA Sponsored ADR Revenue Breakdown – MUN:K5F - TradingView
Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm - GlobeNewswire Inc.
Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm - Barchart.com
Genenta-backed Sòphia sales rise 29.3% to €7.17 million - grafa.com
Genenta Science (GNTA) Jumps 7.6% as Biotech Speculation Heats UpSchiff Line - www.dars.gov.et
Genenta Science (GNTA) Jumps 7.6% as Biotech Speculation Heats UpSocial Sentiment - dars.gov.et
The market is filled with gapping stocks in Wednesday's session. - ChartMill
Genenta Science Regains Full Effectiveness of Corporate Purpose Amendment After Milan Court Ruling - TipRanks
Genenta Science Faces Selling Pressure as Shares Drop 5.66% – Key Levels in FocusRetail Driven Moves - po-news-eg.net
Genenta Science Confirms New Board, Share Buyback and Closes Sòphia High Tech Deal - TipRanks
Enterprise value to EBITDA forward of Genenta Science SpA Sponsored ADR – FWB:K5F - TradingView
Enterprise value to EBIT forward of Genenta Science SpA Sponsored ADR – FWB:K5F - TradingView
Enterprise value to revenue forward of Genenta Science SpA Sponsored ADR – FWB:K5F - TradingView
Price to earnings forward of Genenta Science SpA Sponsored ADR – FWB:K5F - TradingView
Genenta Science Faces Court-Ordered Suspension of Corporate Purpose Amendment While Voting Rights Reform Stands - The Globe and Mail
Genenta Science Faces Court-Ordered Suspension of Corporate Purpose Amendment While Voting Rights Reform Stands - TipRanks
Genenta Science SpA Sponsored ADR Actuals & Estimates (NASDAQ:GNTA) - TradingView
Genenta Science Sets CEO Severance Terms and Narrows Non-Compete in June 2026 - The Globe and Mail
Genenta Science Sets CEO Severance Terms and Narrows Non-Compete in June 2026 - TipRanks
MOB Stock Price and Chart — NASDAQ:MOB - TradingView
GENENTA SCIENCE SPAADR (GNTA) Stock Chart - ChartMill
Genenta Calls June 29 Shareholder Vote on Name Change, Capital Moves and Reverse Split - The Globe and Mail
Genenta Calls June 29 Shareholder Vote on Name Change, Capital Moves and Reverse Split - The Globe and Mail
Genenta Calls June 29 Shareholder Vote on Name Change, Capital Moves and Reverse Split - TipRanks
Genenta Science regains compliance with Nasdaq minimum bid price rule By Investing.com - Investing.com Australia
Genenta Science regains compliance with Nasdaq minimum bid price rule By Investing.com - Investing.com Nigeria
Genenta Science regains compliance with Nasdaq minimum bid price rule By Investing.com - Investing.com India
Genenta Science regains compliance with Nasdaq minimum bid price rule - Investing.com
Genenta Science Regains Compliance with Nasdaq Minimum Bid Price Rule - TipRanks
Genenta sale al 100% della brianzola Atc (fucili per le forze speciali) e nomina il generale Luca Goretti nel cda - Milano Finanza
Unusual volume stocks in Tuesday's session - ChartMill
Unusual volume stocks in Tuesday's session - ChartMill
Which stocks have an unusual volume on Monday? - ChartMill
Which stocks are moving on Monday? - ChartMill
Monday's session: gap up and gap down stocks - ChartMill
Wondering what's happening in today's pre-market session? - ChartMill
Genenta Science Closes All-Share Acquisition of Remaining Stake in A.T.C. - The Globe and Mail
Genenta Science Closes All-Share Acquisition of Remaining Stake in A.T.C. - The Globe and Mail
Genenta Science Closes All-Share Acquisition of Remaining Stake in A.T.C. - TipRanks
GNTAGenenta Science SpA ADR Options - Finviz
On Friday, there are stocks with unusual volume. Let's take a look. - ChartMill
Finanzdaten der Genenta Science Spa Adr-Aktie (GNTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.92%
2.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):